Section Arrow
Quote
BMRN.NASDAQ
- BioMarin Pharmaceutical
Quotes are at least 15-min delayed:2026/04/07 14:55 EDT
Regular Hours
Last
 56.08
-0.13 (-0.23%)
Day High 
56.38 
Prev. Close
56.21 
1-M High
61.97 
Volume 
640.90K 
Bid
56.01
Ask
56.09
Day Low
55.36 
Open
56.11 
1-M Low
53.355 
Market Cap 
10.80B 
Currency 美元 
P/E 30.58 
%Yield -- 
10-SMA 55.44 
20-SMA 56.61 
50-SMA 58.35 
52-W High 66.275 
52-W Low 50.76 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.80/6.16
Enterprise Value
11.40B
Balance Sheet
Book Value Per Share
31.65
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
3.22B
Operating Revenue Per Share
12.03
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QNCXQuince Therapeutics0.1541+0.0666+76.11%-- 
LNAILunai Bioworks Inc.0.3959+0.1139+40.39%-- 
SILOSilo Pharma0.5125+0.1567+44.04%-- 
TERNTerns Pharmaceuticals52.615-0.165-0.31%-- 
CUECue Biopharma0.1841+0.0071+4.01%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.